Search

Your search keyword '"Hasheminejad ZS"' showing total 2 results
Start Over Author "Hasheminejad ZS"
2 results on '"Hasheminejad ZS"'

1. SARS-CoV-2 and Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group.

Author

Shahjouei S, Tsivgoulis G, Farahmand G, Koza E, Mowla A, Vafaei Sadr A, Kia A, Vaghefi Far A, Mondello S, Cernigliaro A, Ranta A, Punter M, Khodadadi F, Naderi S, Sabra M, Ramezani M, Amini Harandi A, Olulana O, Chaudhary D, Lyoubi A, Campbell BCV, Arenillas JF, Bock D, Montaner J, Aghayari Sheikh Neshin S, Aguiar de Sousa D, Tenser MS, Aires A, Alfonso ML, Alizada O, Azevedo E, Goyal N, Babaeepour Z, Banihashemi G, Bonati LH, Cereda CW, Chang JJ, Crnjakovic M, De Marchis GM, Del Sette M, Ebrahimzadeh SA, Farhoudi M, Gandoglia I, Gonçalves B, Griessenauer CJ, Murat Hanci M, Katsanos AH, Krogias C, Leker RR, Lotman L, Mai J, Male S, Malhotra K, Malojcic B, Mesquita T, Mir Ghasemi A, Mohamed Aref H, Mohseni Afshar Z, Moon J, Niemelä M, Rezai Jahromi B, Nolan L, Pandhi A, Park JH, Marto JP, Purroy F, Ranji-Burachaloo S, Carreira NR, Requena M, Rubiera M, Sajedi SA, Sargento-Freitas J, Sharma VK, Steiner T, Tempro K, Turc G, Ahmadzadeh Y, Almasi-Dooghaee M, Assarzadegan F, Babazadeh A, Baharvahdat H, Cardoso FB, Dev A, Ghorbani M, Hamidi A, Hasheminejad ZS, Hojjat-Anasri Komachali S, Khorvash F, Kobeissy F, Mirkarimi H, Mohammadi-Vosough E, Misra D, Noorian AR, Nowrouzi-Sohrabi P, Paybast S, Poorsaadat L, Roozbeh M, Sabayan B, Salehizadeh S, Saberi A, Sepehrnia M, Vahabizad F, Yasuda TA, Ghabaee M, Rahimian N, Harirchian MH, Borhani-Haghighi A, Azarpazhooh MR, Arora R, Ansari S, Avula V, Li J, Abedi V, and Zand R

Subjects
Adult, Aged, COVID-19 epidemiology, Female, Geography, Health Expenditures, Humans, International Cooperation, Intracranial Hemorrhages epidemiology, Ischemic Stroke epidemiology, Male, Middle Aged, Prospective Studies, Risk, Sinus Thrombosis, Intracranial epidemiology, Treatment Outcome, Venous Thrombosis epidemiology, Young Adult, COVID-19 complications, Intracranial Hemorrhages complications, Ischemic Stroke complications, Sinus Thrombosis, Intracranial complications, Venous Thrombosis complications
Abstract

[Figure: see text].

Published
2021
Full Text
View/download PDF

2. COVID-19 Respiratory Illness and Subsequent Cerebrovascular Events, the Initial Iranian Experience.

Author

Sabayan B, Moghadami M, Assarzadegan F, Komachali SH, Poorsaadat L, Babaeepour Z, Ebrahimzadeh SA, Hamidi A, Hasheminejad ZS, Mohammadi-Vosough E, Mirkarimi HR, Paybast S, Rahimian N, Safari A, Sepehrnia M, Nematollahi R, Shahripour RB, Batra A, Sorond F, and Borhani-Haghighi A

Subjects
Adult, Aged, Aged, 80 and over, COVID-19 diagnosis, COVID-19 mortality, COVID-19 therapy, Cerebrovascular Disorders diagnosis, Cerebrovascular Disorders mortality, Cerebrovascular Disorders therapy, Disability Evaluation, Female, Humans, Iran, Male, Middle Aged, Recovery of Function, Risk Factors, Severity of Illness Index, Thrombolytic Therapy, Treatment Outcome, COVID-19 complications, Cerebrovascular Disorders etiology
Abstract

Objectives: COVID-19 disproportionately affects older adults and individuals with cardiovascular co-morbidities. This report presents fifteen patients who had COVID-19 respiratory illness followed by cerebrovascular events., Materials and Methods: A call by the Iranian Neurological Association gathered cases across the country who developed neurological symptoms attributed to hemorrhagic or ischemic stroke after a definite or probable Covid-19 respiratory illness. Definite cases were those with a typical respiratory illness, positive nasopharyngeal Covid-19 PCR test, and chest CT consistent with Covid-19 infection. Probable cases were defined by a typical respiratory illness, history of contacts with a Covid-19 case, and chest CT characteristic for Covid-19 infection., Results: Fifteen patients (12 men and 3 women) with an age range of 38 to 93 years old (median: 65 years old) were included. Fourteen patients had a first-ever acute ischemic stroke and one patient had a subarachnoid hemorrhage. Eleven patients (73%) had previous cardiovascular comorbidities. The median time between respiratory symptoms and neurological symptoms was seven days (range 1-16 days). Stroke severity in two patients was mild (NIHSS ≤ 6), in six patients moderate (NIHSS: 7-12), and in seven patients severe (NIHSS ≥13). One patient received intravenous tissue plasminogen activator ( IV-tPA) with improved neurological symptoms. Six out of 15 patients (40%) died. All but one of those who survived had significant disability assessed by a modified ranking scale >2. The majority of patients in this case series had vascular risk factors and their stroke was associated with severe disability and death., Conclusion: This report highlights the need for further investigation of the links between Covid-19 and cerebrovascular events., Competing Interests: Declaration of Competing Interest Nothing to report., (Copyright © 2020 Elsevier Inc. All rights reserved.)

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results